SLC1A5 增强绕开 NK 细胞转导屏障以递送复杂 CAR 载荷 SLC1A5 augmentation bypasses NK cell transduction barriers to deliver complex CAR payloads. PubMed 2026/06/07 发表J ImmunolQ2 · IF 4(JCR 2025) 靶点:GD2技术:CAR-NK技术:NK 细胞技术:造血干细胞实体瘤地区:美国
TIGIT 通过调节免疫突触强度影响实体瘤微环境中 CAR NK 细胞的效应功能 TIGIT Affects CAR NK-cell Effector Function in the Solid Tumor Microenvironment by Modulating Immune Synapse Strength. PubMed 2025/10/01 发表Cancer Immunol ResQ1 · IF 7.9(JCR 2025) 靶点:GD2技术:CAR-NK技术:NK 细胞血液系统恶性肿瘤实体瘤地区:美国